J. Seyfarth

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

R. Pieters, A. Veerman, J. Harbott, 2000, Blood.

Post-induction residual disease in translocation t(12;21)-positive childhood ALL.

K. Schmiegelow, F. Wesenberg, L. Ryder, 2003, Medical and pediatric oncology.

Mannose-binding lectin and its genetic variants

R. Fujita, P. Garred, H. Madsen, 2006, Genes and Immunity.

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia.

K. Schmiegelow, A. Svejgaard, F. Wesenberg, 2000, Journal of immunological methods.

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance

R. Pieters, R. Pieters, K. Schmiegelow, 2001, Leukemia.

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome.

K. Schmiegelow, Ó. Jónsson, A. Svejgaard, 2002, Blood.

The 'involution' of mannose-binding lectin.

P. Garred, H. Madsen, J. Seyfarth, 2005, Human molecular genetics.

Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes.

P. Garred, Hans O Madsen, Peter Garred, 2006, Molecular immunology.